Evidence map›Paper›PMID 41756136›Full record

ArticleInorganic chemistry frontiers2026

Competitive LC-MS/MS assay to investigate protein metalation dynamics.

Kira Küssner, Michael Wolf, Andrea Cucchiaro, Christian G Hartinger, Samuel Meier-Menches, Monika Cziferszky

Abstract read
In one paragraph

Article in Inorganic chemistry frontiers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kira KüssnerInstitute for Pharmacy, Pharmaceutical Chemistry, Department of Chemistry and Pharmacy, Center for Molecular Bioscience (CMBI), University of Innsbruck Innrain 80/82 A-6020 Innsbruck Austria monika.cziferszky@uibk.ac.at.
Michael WolfInstitute of Analytical Chemistry, Faculty of Chemistry, University of Vienna Waehringer Str. 38 A-1090 Vienna Austria samuel.meier-menches@univie.ac.at.
Andrea CucchiaroInstitute for Pharmacy, Pharmaceutical Chemistry, Department of Chemistry and Pharmacy, Center for Molecular Bioscience (CMBI), University of Innsbruck Innrain 80/82 A-6020 Innsbruck Austria monika.cziferszky@uibk.ac.at.ORCID https://orcid.org/0000-0002-3324-7005
Christian G HartingerFaculty of Science, School of Chemical Science, University of Auckland Science Centre 302 - Bldg 302 23 Symonds St Auckland Central 1010 Auckland New Zealand.ORCID https://orcid.org/0000-0001-9806-0893
Samuel Meier-MenchesInstitute of Analytical Chemistry, Faculty of Chemistry, University of Vienna Waehringer Str. 38 A-1090 Vienna Austria samuel.meier-menches@univie.ac.at.ORCID https://orcid.org/0000-0002-8930-4574
Monika CziferszkyInstitute for Pharmacy, Pharmaceutical Chemistry, Department of Chemistry and Pharmacy, Center for Molecular Bioscience (CMBI), University of Innsbruck Innrain 80/82 A-6020 Innsbruck Austria monika.cziferszky@uibk.ac.at.ORCID https://orcid.org/0000-0002-3654-7812

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge gaps in the biospeciation of potential metallodrugs may lead to the generalized assumption of their promiscuous reactivity and inherent toxicity, neglecting their pharmaceutical potential. Herein, we developed a rapid and competitive LC-MS/MS assay to determine metalation dynamics of protein mixtures by metallodrugs. Specifically, the time-dependent reactivity of different metallodrugs, based on platinum(ii) (cisplatin, [Pt(ala)(ASA-But)Cl]), ruthenium(ii) ([Ru(HQ)(Cym)Cl], [Ru(NHC)(Cym)Cl

Identifiers

PMID41756136
PMCPMC12935058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.